Silence Therapeutics plc Income Statement

Income Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.31M7.04M17.08M21.66M31.64M43.26M
Cost of Revenue 4.83M10.26M13.46M12.87M11.81M
Gross Profit 0.31M2.20M6.82M8.19M18.78M31.45M
Operating items
Amortization - Intangibles 0.03M0.04M0.03M
Research & Development 13.01M17.03M25.95M42.33M43.55M56.94M67.88M
Selling, General & Administrative -14.46M0.00M17.96M27.53M25.68M26.22M26.88M
Other Operating Expenses -80.63M-94.27M-113.62M
Operating Expenses -1.45M17.03M43.91M69.86M-11.39M-11.11M-18.86M
Operating Income -27.47M-29.03M-46.03M-63.03M-61.04M-64.38M-63.32M
EBIT -27.47M-29.03M-46.03M-63.03M-61.04M-64.38M-63.32M
Non-operating items
Interest & Investment Income 0.05M0.03M0.17M0.01M1.57M1.80M
Other Non Operating Income 0.01M0.17M-6.25M-0.42M1.29M-2.64M4.47M
Non Operating Income -0.21M0.41M-0.67M-0.33M-0.31M
Net income details
EBT -27.41M-29.20M-46.28M-63.09M-58.62M-53.27M-44.46M
Tax Provisions -2.82M-4.20M-4.49M-8.87M0.69M0.96M0.84M
Profit After Tax -24.59M-25.00M-41.80M-54.22M-50.33M-54.23M-45.31M
Income from Continuing Operations -24.59M-25.00M-41.80M-54.22M-59.31M-54.23M-45.31M
Consolidated Net Income -24.59M-25.00M-41.80M-54.22M-59.31M-54.23M-45.31M
Income towards Parent Company -24.59M-25.00M-41.80M-54.22M-59.31M-54.23M-45.31M
Net Income towards Common Stockholders -24.59M-25.00M-41.73M-54.21M-50.12M-54.23M-45.31M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 78.37M78.37M89.78M107.68M116.01M141.64M
Shares Outstanding (Diluted Average) 119.53M138.41M138.75M
EBITDA -27.47M-29.03M-46.03M-63.03M-61.04M-64.38M-63.32M
Tax Rate 10.30%14.38%9.69%14.06%